Skip to main content

Table 1 Baseline characteristics of infants receiving early vs deferred ART

From: Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the C hildren with H IV E arly Antir etroviral Therapy (CHER) Study

Variable

Early ART

(n = 75)

Deferred ART

(n = 38)

Total

(n = 113)

P-value

Female (%)

44 (59%)

23 (61%)

67 (59%)

1

Median age (weeks)

7.7

7.0

7.4

0.004

 

(7.1 to 9.4)

(6.5 to 8.5)

(6.9 to 9.2)

 

Median weight for age Z-score

-0.55

-0.16

-0.47

0.08

 

(-1.35 to 0.29)

(-1.02 to 0.55)

(-1.24 to 0.33)

 

WHO Stage

    

I

23 (31%)

14 (37%)

37 (33%)

0.67

II

14 (19%)

5 (13%)

19 (17%)

 

III

38 (50%)

19 (50%)

57 (50%)

 

Median CD4 %

35.2

35.8

35.6

0.89

 

(28.4 to 40.6)

(30.0 to 41.8)

(28.9 to 40.6)

 

Median CD4 count (cells/mm3)

1835

1728

1777

0.27

 

(1362 to 2645)

(1174 to 2195)

(1325 to 2509)

 
  1. Continuous data (IQR)